Cargando…

Optimization of a modeling platform to predict oncogenes from genome‐scale metabolic networks of non‐small‐cell lung cancers

Cancer cell dysregulations result in the abnormal regulation of cellular metabolic pathways. By simulating this metabolic reprogramming using constraint‐based modeling approaches, oncogenes can be predicted, and this knowledge can be used in prognosis and treatment. We introduced a trilevel optimiza...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, You‐Tyun, Lin, Min‐Ru, Chen, Wei‐Chen, Wu, Wu‐Hsiung, Wang, Feng‐Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329960/ https://www.ncbi.nlm.nih.gov/pubmed/34137202 http://dx.doi.org/10.1002/2211-5463.13231

Ejemplares similares

Genome-Scale Metabolic Modeling with Protein Expressions of Normal and Cancerous Colorectal Tissues for Oncogene Inference
por: Wang, Feng-Sheng, et al.
Publicado: (2019)

Multi-objective optimization of enzyme manipulations in metabolic networks considering resilience effects
por: Wu, Wu-Hsiung, et al.
Publicado: (2011)

Oncogene inference optimization using constraint-based modelling incorporated with protein expression in normal and tumour tissues
por: Wu, Wu-Hsiung, et al.
Publicado: (2020)

Genome-scale metabolic network reconstruction of model animals as a platform for translational research
por: Wang, Hao, et al.
Publicado: (2021)

Evaluation of the Oncogene Function of GOLPH3 and Correlated Regulatory Network in Lung Adenocarcinoma
por: Zhang, Tong, et al.
Publicado: (2021)

Optimal knockout strategies in genome-scale metabolic networks using particle swarm optimization
por: Nair, Govind, et al.
Publicado: (2017)

MEMOSys: Bioinformatics platform for genome-scale metabolic models
por: Pabinger, Stephan, et al.
Publicado: (2011)

Computer-Aided Design for Identifying Anticancer Targets in Genome-Scale Metabolic Models of Colon Cancer
por: Cheng, Chao-Ting, et al.
Publicado: (2021)

GRK5 functions as an oncogenic factor in non-small-cell lung cancer
por: Jiang, Li-Ping, et al.
Publicado: (2018)

BatchGenAna: a batch platform for large-scale genomic analysis of mammalian small RNAs
por: Ying, Xiaomin, et al.
Publicado: (2009)

Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis
por: Mei, Y, et al.
Publicado: (2011)

A Single-Institute Experience with C-ros Oncogene 1 Translocation in Non-Small Cell Lung Cancers in Taiwan
por: Wang, Hsiang-Sheng, et al.
Publicado: (2022)

OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers
por: Wang, Tao, et al.
Publicado: (2020)

Alterations of RET, Oncogene in Human Adrenal Tumors
por: Lin, Shiu‐Ru, et al.
Publicado: (1998)

In Silico Evaluation of HN-N07 Small Molecule as an Inhibitor of Angiogenesis and Lymphangiogenesis Oncogenic Signatures in Non-Small Cell Lung Cancer
por: Chen, Lung-Ching, et al.
Publicado: (2023)

Evidence for an oncogenic role of HOXC6 in human non-small cell lung cancer
por: Yang, Yingcheng, et al.
Publicado: (2019)

Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer
por: Shao, Yang, et al.
Publicado: (2016)

Design of a Network Optimization Platform for the Multivehicle Transportation of Hazardous Materials
por: Dong, Sheng, et al.
Publicado: (2020)

IMGMD: A platform for the integration and standardisation of In silico Microbial Genome-scale Metabolic Models
por: Ye, Chao, et al.
Publicado: (2017)

Risk of thromboembolism in non-small-cell lung cancers patients with different oncogenic drivers, including ROS1, ALK, and EGFR mutations
por: Wang, H.-Y., et al.
Publicado: (2022)

BATF acts as an oncogene in non-small cell lung cancer
por: Feng, Yu, et al.
Publicado: (2020)

Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer
por: Sunaga, Noriaki, et al.
Publicado: (2021)

Immunotherapy in oncogene addicted non-small cell lung cancer
por: McLean, Luke, et al.
Publicado: (2021)

Robust, small-scale cultivation platform for Streptomyces coelicolor
por: Sohoni, Sujata Vijay, et al.
Publicado: (2012)

Identifying optimal first-line immune checkpoint inhibitors based regiments for advanced non-small cell lung cancer without oncogenic driver mutations: A systematic review and network meta-analysis
por: Liu, Tingting, et al.
Publicado: (2023)

ZYG11A serves as an oncogene in non-small cell lung cancer and influences CCNE1 expression
por: Wang, Xin, et al.
Publicado: (2016)

Oncogenic EFNA4 Amplification Promotes Lung Adenocarcinoma Lymph Node Metastasis
por: Zhao, Xiangyu, et al.
Publicado: (2022)

Possible Oncogenic Viruses Associated with Lung Cancer
por: Hu, Yan, et al.
Publicado: (2020)

Randomizing Genome-Scale Metabolic Networks
por: Samal, Areejit, et al.
Publicado: (2011)

Co-Occurring Potentially Actionable Oncogenic Drivers in Non-Small Cell Lung Cancer
por: Zhao, Yiming, et al.
Publicado: (2021)

Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent
por: You, Ming-Liang, et al.
Publicado: (2017)

Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancer
por: Mitra, Ramkrishna, et al.
Publicado: (2014)

KRAS oncogene may be another target conquered in non‐small cell lung cancer (NSCLC)
por: Chen, Hanxiao, et al.
Publicado: (2020)

Comprehensive investigation of oncogenic driver mutations in Chinese non-small cell lung cancer patients
por: Wang, Rui, et al.
Publicado: (2015)

MITF functions as a tumor suppressor in non-small cell lung cancer beyond the canonically oncogenic role
por: Hsiao, Yi-Jing, et al.
Publicado: (2020)

RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer
por: Wang, Chunyue, et al.
Publicado: (2022)

Oncogenic Genetic Alterations in Non-Small-Cell Lung Cancer (NSCLC) in Southwestern China
por: Ma, Yuhui, et al.
Publicado: (2020)

Bioinformatics of non small cell lung cancer and the ras proto-oncogene
por: Kashyap, Amita, et al.
Publicado: (2015)

Role of Immunotherapy for Oncogene-Driven Non-Small Cell Lung Cancer
por: Miura, Yosuke, et al.
Publicado: (2018)

Efficacy of immunotherapy in oncogene-driven non-small-cell lung cancer
por: Vokes, Natalie I., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_thu83akqssf9lloda4e95989jh